Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies

AIMS: Thrombocytopenia complicates the management of patients with chronic liver disease (CLD) undergoing invasive procedures with a bleeding risk. Until recently, prophylactic platelet transfusion was the only treatment option, but has significant safety and efficacy limitations. Phase 3 data demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Poordad, Fred, Terrault, Norah A., Alkhouri, Naim, Tian, Wei, Allen, Lee F., Rabinovitz, Mordechai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003278/
https://www.ncbi.nlm.nih.gov/pubmed/32047671
http://dx.doi.org/10.1155/2020/5421632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003278/
https://www.ncbi.nlm.nih.gov/pubmed/32047671
http://dx.doi.org/10.1155/2020/5421632

Ejemplares similares